Cicatricial ectropion associated with treatment of metastatic colorectal cancer with cetuximab

Ophthalmic Plastic and Reconstructive Surgery

Volumn 23, Issue 1, 2007, Pages 62-63

  Garibaldi, Daniel C ^a   Adler, Richard A ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Katzen Eye Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; CETUXIMAB; DESONIDE; ERYTHROMYCIN; FLUOROURACIL; IRINOTECAN; STEROID;

ADD ON THERAPY; ADULT; ARTICLE; CANCER PATIENT; CASE REPORT; COLORECTAL CANCER; CONJUNCTIVA; CONSULTATION; DISEASE ASSOCIATION; DRUG INFUSION; DRUG WITHDRAWAL; ECTROPION; EPIPHORA; EYE EXAMINATION; EYELASH; EYELID DISEASE; FOLLOW UP; HUMAN; MADAROSIS; MALE; METASTASIS; PRIORITY JOURNAL; PUPIL REFLEX; SKIN IRRITATION; SLIT LAMP; SYMPTOMATOLOGY; VISUAL ACUITY;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CICATRIX; COLONIC NEOPLASMS; ECTROPION; HUMANS; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN;

EID: 33846459000     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e31802d9025     Document Type: Article

References (6)

1. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351:337-45.
2. Dueland S, Sauer T, Lund-Johansen F. Epidermal growth factor receptor inhibition induces trichomegaly. Acta Oncol 2003;42:345-6.
3. Busam KJ, Capodieci P, Motzer R, et al. Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. Br J Dermatol 2001;144:1169-76.
4. Perez-Soler R, Saltz L. Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining? J Clin Oncol 2005;23:5235-46.
5. Hurwitz BS. Cicatricial ectropion: a complication of systemic fluorouracil. Arch Ophthalmol 1993;111:1608-9.
6. Straus DJ, Mausolf FA, Ellerby RA, McCracken JD. Cicatricial ectropion secondary to 5-flurouracil therapy. Med Pediatr Oncol 1977;3:15-9.